2018 Patient Navigation Initiative: 2nd Annual Conference

Monday, February 5, 2018
8:30 AM - 4:30 PM
The Recital Hall
CUNY Graduate Center
365 Fifth Avenue
New York, NY 10016

Patient Navigation Initiative:
2nd Annual Conference

Monday, February, 5th, 2018
8:30 AM - 4:30 PM
The CUNY Graduate Center (map)
365 Fifth Avenue — New York, NY 10016 Registration opens at 8:30 AM. Enjoy coffee and light refreshments for breakfast; lunch will be served midday

Join Susan G. Komen Greater New York City for a series of conversations about the future of patient navigation in decision-making throughout the breast health continuum of care. We'll focus on how providers, industry/pharma, elected officials, and advocates can continue to strengthen and institutionalize this vital service for all New Yorkers.

The event will address the latest legislative efforts, improvements to standardization challenges, fractionalization of care, and cultural competency within the healthcare environment. Giving voice to our collective efforts, conference participants will be invited to play a leading role in our comprehensive public relations and advocacy efforts.

Just confirmed:
  • Savitiri Basavaiah
    Senior Director, Portfolio Marketing & Customer Engagement, Pfizer Oncology
  • Patrick I. Borgen, MD
    Chairman of Surgery, Maimonides Medical Center
  • Zenobia Brown, MD, MPH
    Vice President and Medical Director, Northwell Health Solutions, Population Health Management
  • Marni Tierno, RN, PhD
    Genomic Health's Medical Science Liason
  • Victoria Wolodsko
    Vice President Research and Community Health Program Operations, Susan G. Komen
  • Howard A. Zucker, M.D
    New York State Health Commissioner

We will start the day with a Genomics training

Marni Tierno, Genomic Health's Medical Science Liason will provide an overview on genomics and the importance of Genomic Testing testing for your patient's care.

Referencing “The Oncotype DX Breast Cancer Assay in Contemporary Management of ER+/HER2- Early-Stage Breast Cancer,” Ms. Tierno will walk you through how to 1) Understand the prognostic and predictive value of the Oncotype DX Recurrence Score in ER+/HER2- early stage invasive breast cancer patient; 2) Acknowledge chemotherapy treatment decisions and utilization with increasing Recurrence Scores in line with national and international guidelines; and 3) Understand recent changes to the AJCC Cancer Staging Manual, 8th Edition, in regards to incorporation of biomarkers and Oncotype DX for individualized staging of ER+/HER2- invasive breast cancer.

Susan G. Komen Greater New York City's Patient Navigation Initiative is made possible by a grant from:
The Allergan Foundation Pfizer Oncology Genomic Health. Life, Changing.

Additional financial support is provided by
W. Stewart McKeough and Nadine Karachi-Estrada.

For more information please contact PNI@komennyc.org.

We're sorry, the deadline for buying tickets for this event has passed.